Literature DB >> 29950592

The case for nonsurgical therapy of nonmetastatic penile cancer.

Jonathan Tward1.   

Abstract

Invasive squamous cell carcinoma (SCC) of the penis is almost always treated with surgical therapy at the primary site. However, almost all other SCC primary sites, such as anal, vulvar, uterine cervix, head and neck, and oesophagus, and their involved nodal basins, can be successfully treated with radiotherapy or combined chemotherapy and radiation, reserving surgery as a salvage option. Review of the penile cancer literature and examination of data from more common SCC primary sites make a case for complete organ preservation of the penis using definitive combined chemotherapy and radiation, reserving surgical therapies as salvage options.

Entities:  

Mesh:

Year:  2018        PMID: 29950592     DOI: 10.1038/s41585-018-0040-y

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  2 in total

Review 1.  Immune-based therapies in penile cancer.

Authors:  Vidhu B Joshi; Philippe E Spiess; Andrea Necchi; Curtis A Pettaway; Jad Chahoud
Journal:  Nat Rev Urol       Date:  2022-07-18       Impact factor: 16.430

Review 2.  Understanding genomics and the immune environment of penile cancer to improve therapy.

Authors:  Ahmet Murat Aydin; Jad Chahoud; Jacob J Adashek; Mounsif Azizi; Anthony Magliocco; Jeffrey S Ross; Andrea Necchi; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2020-08-18       Impact factor: 14.432

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.